The present study provides evidence that PD‐1 participates in the generation of epilepsy, identifying PD‐1 as a novel endogenous epileptogenic factor and anti‐PD‐1 treatment as a novel therapeutic strategy for epilepsy and, potentially, for other neurological diseases. This evidence concerns the gene PDCD1 and nervous system disorder.